Abstract:figure legend Circulating noradrenaline (NA) stimulates the release of neuropeptide Y (NPY) from presynaptic sympathetic nerve terminals via activation of β‐adrenergic receptors (β‐R). This NA‐induced NPY release can be inhibited by the β‐blocker propranolol, suggesting that this mechanism, which enhances sympathoexcitation, is mediated via β‐adrenergic receptors. Cardiac disease is marked by sympathoexcitation and elevated levels of noradrenaline (NA) and cotransmitter neuropeptide Y (NPY). Increased NPY levels are associated with a greater risk of ventricular arrhythmias and mortality. Nonetheless, the factors that cause NPY release remain poorly understood. We hypothesized that circulating catecholamines might lead to NPY release from myocardial sympathetic nerve terminals via a β‐receptor‐mediated mechanism that enhances sympathoexcitation. Ventricular interstitial NA and NPY levels were measured in six Yorkshire pigs after i.v. administration of NA (1 mg) and before and after propranolol infusion (1 mg/kg). Real‐time interstitial NPY levels were measured using ventricular capacitive immunoprobes (CIs) affixed with NPY antibodies and quantified as the change in CI input current (INPY) upon binding of NPY. Interstitial NA was measured with adjacent fast‐scan cyclic voltammetry probes (INA). A left ventricular pressure catheter and continuous ECGs were used for haemodynamic recordings, and an epicardial 56‐electrode sock was used for measurements of activation recovery interval, a surrogate of action potential duration. Upon administration of NA, heart rate and left ventricular pressure increased, and activation recovery interval shortened. Notably, NA significantly increased interstitial myocardial NPY levels. After propranolol, changes in heart rate and activation recovery interval were largely mitigated. The INA increased to a similar extent post‐propranolol vs. pre‐propranolol, but changes in INPY were significantly reduced post‐propranolol. Coronary sinus plasma analyses confirmed fast‐scan cyclic voltammetry and CI findings. Hence, this study demonstrates that circulating NA induces NPY release from ventricular sympathetic nerve terminals, the mechanism for which is mediated via β‐adrenergic receptors and can be blocked by the non‐selective β‐blocker, propranolol. Key points Cardiovascular disease is characterized by sympathovagal imbalance, with increased plasma noradrenaline (NA) and neuropeptide Y (NPY) concentrations. Increased NPY levels are associated with increased ventricular arrhythmias and mortality in heart failure. Limited data are available on the specific factors that cause NPY release. In this study, fast‐scan cyclic voltammetry and capacitive immunoprobes were used to allow for real‐time in vivo measurements of interstitial myocardial neurotransmitters and neuropeptides, respectively. Using an in vivo porcine model with cardiac fast‐scan cyclic voltammetry and capacitive immunoprobes, it was shown that systemic NA can increase ventricular interstitial NPY levels, suggesting that NA induces NPY release from postganglionic sympathetic nerves. The release of NPY was blocked by administration of the non‐selective β‐blocker propranolol, suggesting that release of NPY is dependent on activation of β‐adrenergic receptors by NA.

Cardiorespiratory Responses to Intracerebroventricular Injection of Neuropeptide Y in Anaesthetised Dogs

Cardiovascular Effects of Intracerebral Injection of Neuropeptide Y in Rats.

[Roles of the Central Nucleus of Amygdala in the Cardiovascular Response Elicited by the Paraventricular Nucleus of Hypothalamus].

Effects of M(1) and M(2) Receptor Agonists and Blockers on Dog Respiration

Circulating noradrenaline leads to release of neuropeptide Y from cardiac sympathetic nerve terminals via activation of β‐adrenergic receptors

Neuropeptide-Y Inhibition of Nicotinic Receptor-Mediated Chromaffin Cell Secretion

Pressor and Tachycardic Responses to Intrathecal Administration of Neuropeptide FF in Anesthetized Rats

Cardiovascular Actions of Central Neuropeptide W in Conscious Rats

The effects of intrathecal domestic levobupivacaine hydrochloride on spinal cord and nerve roots in dogs

Valence-dependent effects of neuropeptide Y on the expression of conditioned fear and anxiety-like behavior: Involvement of the bed nucleus of the stria terminalis

[Inhibitory Effect of 6 Beta-Acetoxy Nortropane on Respiration].

Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission

Intranasal administration of neuropeptide Y significantly antagonized stress-induced colonic dysmotility via central GABAA receptors in male rats

EFFECTS OF ATRIAL-NATRIURETIC-FACTOR ON BLOOD-FLOW DISTRIBUTION AND VASCULAR-RESISTANCE IN CONSCIOUS DOGS

Effects of intracerebroventricular administration of neuropeptide W30 on neurons in the hypothalamic paraventricular nucleus in the conscious rat

Regulation of Neuropeptide Y in Central Nucleus of Amygdaloid on Feeding of Fasted Rats

Role of Cardiac Nerves in the Cardiovascular Response to Cocaine in Conscious Dogs

Both coiling and clipping induce the time-dependent release of endogenous neuropeptide Y into serum

Neuropeptide Y Enhances Permeability Across a Rat Aortic Endothelial Cell Monolayer

An Animal And Clinical Study On The Change Of Neuropeptide Y Release Evoked By Electrical Stimulation And Myocardial Ischemia

Effects of Neuropeptide Y on the Microvasculature of Human Skeletal Muscle.